Our results demonstrated that supplementing gnetin C to the HFCD diet can effectively protect mice from developing NAFLD pathology by reducing liver weight, BW, and blood glucose levels, improving insulin sensitivity, and inhibiting liver steatosis and fibrosis. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.